{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:39:21Z","timestamp":1793659161809,"version":"4.5.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10787-025-02033-0","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T01:34:58Z","timestamp":1763775298000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Persistent inflammatory cytokine signature in long Covid-19 patients: a meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4730-5947","authenticated-orcid":false,"given":"Waleska","family":"Dornas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Pedro","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tales Eduardo","family":"Belilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Gomes","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Horta","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de Lourdes","family":"de Souza Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Gomes","family":"Tcherniacovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes Coral Contreras","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helton","family":"C Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"15","key":"2033_CR1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161167","volume":"132","author":"J Ahamed","year":"2022","unstructured":"Ahamed J, Laurence J (2022) Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest 132(15):e161167","journal-title":"J Clin Invest"},{"issue":"7","key":"2033_CR2","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","volume":"28","author":"Z Al-Aly","year":"2022","unstructured":"Al-Aly Z, Bowe B, Xie Y (2022) Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 28(7):1461\u20131467","journal-title":"Nat Med"},{"key":"2033_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1067082","volume":"9","author":"AA Alfadda","year":"2022","unstructured":"Alfadda AA, Rafiullah M, Alkhowaiter M et al (2022) Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: a prospective follow-up investigation. Front Med 9:1067082","journal-title":"Front Med"},{"issue":"10","key":"2033_CR4","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.3390\/microorganisms11102396","volume":"11","author":"J Alonso-Dom\u00ednguez","year":"2023","unstructured":"Alonso-Dom\u00ednguez J, Gallego-Rodr\u00edguez M, Mart\u00ednez-Barros I et al (2023) High levels of IL-1\u03b2, TNF-\u03b1 and MIP-1\u03b1 one month after the onset of the acute SARS-CoV-2 infection, predictors of post COVID-19 in hospitalized patients. Microorganisms 11(10):2396","journal-title":"Microorganisms"},{"issue":"5","key":"2033_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00011-023-01726-y","volume":"72","author":"RDN Arifa","year":"2023","unstructured":"Arifa RDN, Gon\u00e7alves-Pereira MH, Santiago L et al (2023) Reduction in the number of neutrophils in the broncho-alveolar aspirate is associated with worse prognosis in elderly patients with severe COVID-19. Inflamm Res 72(5):929\u2013932","journal-title":"Inflamm Res"},{"key":"2033_CR6","doi-asserted-by":"publisher","first-page":"1038227","DOI":"10.3389\/fimmu.2022.1038227","volume":"13","author":"M Bellan","year":"2022","unstructured":"Bellan M, Apostolo D, Alb\u00e8 A et al (2022) Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: a prospective cohort study. Front Immunol 13:1038227","journal-title":"Front Immunol"},{"issue":"1","key":"2033_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.immuni.2010.01.009","volume":"32","author":"GT Belz","year":"2010","unstructured":"Belz GT, Masson F (2010) Interleukin-2 tickles T cell memory. Immunity 32(1):7\u20139","journal-title":"Immunity"},{"key":"2033_CR8","doi-asserted-by":"publisher","first-page":"1254899","DOI":"10.3389\/fimmu.2023.1254899","volume":"14","author":"JC Berentschot","year":"2023","unstructured":"Berentschot JC, Drexhage HA, Aynekulu Mersha DG et al (2023) Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity. Front Immunol 14:1254899","journal-title":"Front Immunol"},{"issue":"4","key":"2033_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2024.152813","volume":"229","author":"L Bergantini","year":"2024","unstructured":"Bergantini L, Gangi S, d\u2019Alessandro M et al (2024) Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19. Immunobiology 229(4):152813","journal-title":"Immunobiology"},{"key":"2033_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bbi.2023.11.028","volume":"116","author":"B Besteher","year":"2024","unstructured":"Besteher B, Rockt\u00e4schel T, Garza AP et al (2024) Cortical thickness alterations and systemic inflammation define long-COVID patients with cognitive impairment. Brain Behav Immun 116:175\u2013184","journal-title":"Brain Behav Immun"},{"key":"2033_CR11","doi-asserted-by":"publisher","first-page":"1090747","DOI":"10.3389\/fneur.2023.1090747","volume":"14","author":"H Bonilla","year":"2023","unstructured":"Bonilla H, Quach TC, Tiwari A et al (2023) Myalgic encephalomyelitis\/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol 14:1090747","journal-title":"Front Neurol"},{"issue":"4","key":"2033_CR12","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00431-021-04345-z","volume":"181","author":"L Borch","year":"2022","unstructured":"Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S (2022) Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr 181(4):1597\u20131607","journal-title":"Eur J Pediatr"},{"key":"2033_CR13","doi-asserted-by":"publisher","first-page":"1161067","DOI":"10.3389\/fimmu.2023.1161067","volume":"14","author":"V Carlini","year":"2023","unstructured":"Carlini V, Noonan DM, Abdalalem E et al (2023) The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front Immunol 14:1161067","journal-title":"Front Immunol"},{"issue":"1","key":"2033_CR14","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-021-27797-1","volume":"13","author":"C Cervia","year":"2022","unstructured":"Cervia C, Zurbuchen Y, Taeschler P et al (2022) Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun 13(1):446","journal-title":"Nat Commun"},{"key":"2033_CR15","doi-asserted-by":"publisher","first-page":"1335352","DOI":"10.3389\/fimmu.2023.1335352","volume":"14","author":"R Cezar","year":"2024","unstructured":"Cezar R, Kundura L, Andr\u00e9 S et al (2024) T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVID. Front Immunol 14:1335352","journal-title":"Front Immunol"},{"key":"2033_CR16","doi-asserted-by":"publisher","first-page":"1006076","DOI":"10.3389\/fimmu.2022.1006076","volume":"13","author":"HL Corr\u00eaa","year":"2022","unstructured":"Corr\u00eaa HL, Deus LA, Ara\u00fajo TB et al (2022) Phosphate and IL-10 concentration as predictors of long-covid in hemodialysis patients: a Brazilian study. Front Immunol 13:1006076","journal-title":"Front Immunol"},{"key":"2033_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1376030","volume":"11","author":"C Delfino","year":"2024","unstructured":"Delfino C, Poli MC, Vial C et al (2024) Post-COVID-19 condition: a sex-based analysis of clinical and laboratory trends. Front Med 11:1376030","journal-title":"Front Med"},{"issue":"3","key":"2033_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/vaccines11030699","volume":"11","author":"M Dhawan","year":"2023","unstructured":"Dhawan M, Rabaan AA, Alwarthan S et al (2023) Regulatory T cells (Tregs) and COVID-19: unveiling the mechanisms, and therapeutic potentialities with a special focus on long COVID. Vaccines (Basel) 11(3):699","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"2033_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41541-024-00815-1","volume":"9","author":"C Fischer","year":"2024","unstructured":"Fischer C, Willscher E, Paschold L et al (2024) SARS-CoV-2 vaccination may mitigate dysregulation of IL-1\/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition. NPJ Vaccines 9(1):23","journal-title":"NPJ Vaccines"},{"key":"2033_CR20","doi-asserted-by":"publisher","first-page":"175628642412295","DOI":"10.1177\/17562864241229567","volume":"17","author":"M Fleischer","year":"2024","unstructured":"Fleischer M, Szepanowski F, Mausberg AK et al (2024) Cytokines (IL1\u03b2, IL6, TNF\u03b1) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19. Ther Adv Neurol Disord 17:17562864241229568","journal-title":"Ther Adv Neurol Disord"},{"issue":"5","key":"2033_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28774","volume":"95","author":"SW Fong","year":"2023","unstructured":"Fong SW, Goh YS, Torres-Ruesta A et al (2023) Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection. J Med Virol 95(5):e28774","journal-title":"J Med Virol"},{"issue":"1","key":"2033_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.70123","volume":"13","author":"S Gangi","year":"2025","unstructured":"Gangi S, Bergantini L, Paggi I et al (2025) Regulatory T cell phenotype related to cytokine expression patterns in post-COVID-19 pulmonary fibrosis and idiopathic pulmonary fibrosis. Immunity Inflamm Dis 13(1):e70123","journal-title":"Immunity Inflamm Dis"},{"key":"2033_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.920627","volume":"13","author":"J Garc\u00eda-Abell\u00e1n","year":"2022","unstructured":"Garc\u00eda-Abell\u00e1n J, Fern\u00e1ndez M, Padilla S et al (2022) Immunologic phenotype of patients with long-COVID syndrome of 1-year duration. Front Immunol 13:920627","journal-title":"Front Immunol"},{"key":"2033_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156295","volume":"169","author":"M Garcia-Gasalla","year":"2023","unstructured":"Garcia-Gasalla M, Berman-Riu M, Rodriguez A et al (2023) Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition. Cytokine 169:156295","journal-title":"Cytokine"},{"issue":"8","key":"2033_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","volume":"8","author":"PM George","year":"2020","unstructured":"George PM, Wells AU, Jenkins RG (2020) Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 8(8):807\u2013815","journal-title":"Lancet Respir Med"},{"issue":"4","key":"2033_CR26","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00542-2020","volume":"6","author":"YMJ Go\u00ebrtz","year":"2020","unstructured":"Go\u00ebrtz YMJ, Van Herck M, Delbressine JM et al (2020) Persistent symptoms 3\u2005months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 6(4):00542\u20132020","journal-title":"ERJ Open Res"},{"issue":"4","key":"2033_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283983","volume":"18","author":"SMR Gomes","year":"2023","unstructured":"Gomes SMR, Brito ACS, Manfro WFP et al (2023) High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients. PLoS ONE 18(4):e0283983","journal-title":"PLoS ONE"},{"issue":"4","key":"2033_CR28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/imm.13603","volume":"168","author":"MH Gon\u00e7alves-Pereira","year":"2023","unstructured":"Gon\u00e7alves-Pereira MH, Santiago L, Ravetti CG et al (2023) Dysfunctional phenotype of systemic and pulmonary regulatory T cells associate with lethal COVID-19 cases. Immunology 168(4):684\u2013696","journal-title":"Immunology"},{"issue":"9","key":"2033_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae462","volume":"11","author":"DO Griffin","year":"2024","unstructured":"Griffin DO (2024) Postacute sequelae of COVID (PASC or long COVID): an evidenced-based approach. Open Forum Infect Dis 11(9):ofae462 (Erratum. In: Open Forum Infect Dis. 2024;11(9):ofae509)","journal-title":"Open Forum Infect Dis"},{"key":"2033_CR30","doi-asserted-by":"publisher","first-page":"1070994","DOI":"10.3389\/fimmu.2022.1070994","volume":"13","author":"S Haunhorst","year":"2022","unstructured":"Haunhorst S, Bloch W, Javelle F et al (2022) A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of long COVID? Front Immunol 13:1070994","journal-title":"Front Immunol"},{"key":"2033_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109634","volume":"252","author":"AD Hoffmann","year":"2023","unstructured":"Hoffmann AD, Weinberg SE, Swaminathan S et al (2023) Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients. Clin Immunol 252:109634","journal-title":"Clin Immunol"},{"issue":"2","key":"2033_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11(2):193\u2013206","journal-title":"Psychol Methods"},{"issue":"8","key":"2033_CR33","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1164\/rccm.200407-857OC","volume":"171","author":"Y Jiang","year":"2005","unstructured":"Jiang Y, Xu J, Zhou C et al (2005) Characterization of cytokine\/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med 171(8):850\u2013857","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2033_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.859","volume":"11","author":"P Kamanzi","year":"2023","unstructured":"Kamanzi P, Mulundu G, Mutale K, Mumba C, Ngalamika O (2023) HIV and inflammatory markers are associated with persistent COVID-19 symptoms. Immun Inflamm Dis 11(5):e859","journal-title":"Immun Inflamm Dis"},{"key":"2033_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2021.105295","volume":"131","author":"N Kappelmann","year":"2021","unstructured":"Kappelmann N, Dantzer R, Khandaker GM (2021) Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology 131:105295","journal-title":"Psychoneuroendocrinology"},{"issue":"5\u20136","key":"2033_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/1073858420941476","volume":"26","author":"D Kempuraj","year":"2020","unstructured":"Kempuraj D, Selvakumar GP, Ahmed ME et al (2020) COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist 26(5\u20136):402\u2013414","journal-title":"Neuroscientist"},{"issue":"5","key":"2033_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010359","volume":"18","author":"KM Littlefield","year":"2022","unstructured":"Littlefield KM, Watson RO, Schneider JM et al (2022) SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog 18(5):e1010359","journal-title":"PLoS Pathog"},{"issue":"1","key":"2033_CR38","doi-asserted-by":"publisher","first-page":"12420","DOI":"10.1038\/s41598-023-39049-x","volume":"13","author":"Y L\u00f3pez-Hern\u00e1ndez","year":"2023","unstructured":"L\u00f3pez-Hern\u00e1ndez Y, Mon\u00e1rrez-Espino J, L\u00f3pez DAG et al (2023) The plasma metabolome of long COVID patients two years after infection. Sci Rep 13(1):12420","journal-title":"Sci Rep"},{"issue":"59","key":"2033_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abh2259","volume":"6","author":"L Ma","year":"2021","unstructured":"Ma L, Sahu SK, Cano M et al (2021) Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci Immunol 6(59):eabh2259","journal-title":"Sci Immunol"},{"issue":"10","key":"2033_CR40","first-page":"1891","volume":"29","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Morrone MC, Patrono C, Santoro MG, Schiaffino S, Remuzzi G, Bussolati G (2022) Covid-19 Commission of the Accademia Nazionale dei Lincei. Long Covid: where we stand and challenges ahead. Cell Death Differ 29(10):1891\u20131900","journal-title":"Cell Death Differ"},{"issue":"2","key":"2033_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","volume":"23","author":"S Mehandru","year":"2022","unstructured":"Mehandru S, Merad M (2022) Pathological sequelae of long-haul COVID. Nat Immunol 23(2):194\u2013202","journal-title":"Nat Immunol"},{"key":"2033_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.902140","volume":"13","author":"C Meisinger","year":"2022","unstructured":"Meisinger C, Go\u00dflau Y, Warm TD et al (2022) Post-COVID-19 fatigue and SARS-CoV-2 specific humoral and T-cell responses in male and female outpatients. Front Immunol 13:902140","journal-title":"Front Immunol"},{"issue":"1","key":"2033_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","volume":"19","author":"S Montazersaheb","year":"2022","unstructured":"Montazersaheb S, Hosseiniyan Khatibi SM et al (2022) COVID-19 infection: an overview on cytokine storm and related interventions. Virol J 19(1):92","journal-title":"Virol J"},{"issue":"1","key":"2033_CR44","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jtha.2023.09.022","volume":"22","author":"A Mroueh","year":"2024","unstructured":"Mroueh A, Fakih W, Carmona A et al (2024) COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines\/SGLT2 prooxidant pathway. J Thromb Haemost 22(1):286\u2013299","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2033_CR45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A et al (2021) Post-acute COVID-19 syndrome. Nat Med 27(4):601\u2013615","journal-title":"Nat Med"},{"issue":"4","key":"2033_CR46","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.immuni.2022.03.016","volume":"55","author":"C Nathan","year":"2022","unstructured":"Nathan C (2022) Nonresolving inflammation redux. Immunity 55(4):592\u2013605","journal-title":"Immunity"},{"key":"2033_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.102228","volume":"77","author":"KL Newell","year":"2022","unstructured":"Newell KL, Waickman AT (2022) Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionimmunity and inflammaion in post-acute sequelae of SARS-CoV-2 infection. Curr Opin Immunol 77:102228","journal-title":"Curr Opin Immunol"},{"key":"2033_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2022.106975","volume":"144","author":"E Oikonomou","year":"2022","unstructured":"Oikonomou E, Souvaliotis N, Lampsas S et al (2022) Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vascul Pharmacol 144:106975","journal-title":"Vascul Pharmacol"},{"issue":"9","key":"2033_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110839","volume":"27","author":"B Oliv\u00e1n-Bl\u00e1zquez","year":"2024","unstructured":"Oliv\u00e1n-Bl\u00e1zquez B, Bona-Otal M, M\u00e9ndez-L\u00f3pez F et al (2024) Characterization model of the post COVID-19 condition based on immunological, biochemical, and cytokine markers. iScience 27(9):110839","journal-title":"iScience"},{"issue":"6","key":"2033_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab156","volume":"8","author":"SWX Ong","year":"2021","unstructured":"Ong SWX, Fong SW, Young BE et al (2021) Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open Forum Infect Dis 8(6):ofab156","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2033_CR51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12016-021-08848-3","volume":"64","author":"B Oronsky","year":"2023","unstructured":"Oronsky B, Larson C, Hammond TC et al (2023) A Review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol 64(1):66\u201374","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"2033_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10(1):89","journal-title":"Syst Rev"},{"issue":"6","key":"2033_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109518","volume":"36","author":"MJ Peluso","year":"2021","unstructured":"Peluso MJ, Deitchman AN, Torres L et al (2021a) Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep 36(6):109518","journal-title":"Cell Rep"},{"issue":"11","key":"2033_CR54","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/infdis\/jiab490","volume":"224","author":"MJ Peluso","year":"2021","unstructured":"Peluso MJ, Lu S, Tang AF et al (2021b) Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis 224(11):1839\u20131848","journal-title":"J Infect Dis"},{"key":"2033_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110055","volume":"144","author":"R Perrin","year":"2020","unstructured":"Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A (2020) Into the looking glass: post-viral syndrome post COVID-19. Med Hypotheses 144:110055","journal-title":"Med Hypotheses"},{"key":"2033_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.922422","volume":"12","author":"MAF Queiroz","year":"2022","unstructured":"Queiroz MAF, Neves PFMD, Lima SS et al (2022) Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol 12:922422","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2033_CR57","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1038\/s41598-024-55696-0","volume":"14","author":"MAF Queiroz","year":"2024","unstructured":"Queiroz MAF, Brito WRDS, Pereira KAS et al (2024) Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-\u03b1. Sci Rep 14(1):4974","journal-title":"Sci Rep"},{"key":"2033_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121750","volume":"324","author":"CM Queiroz-Junior","year":"2023","unstructured":"Queiroz-Junior CM, Santos ACPM, Gon\u00e7alves MR et al (2023) Acute coronavirus infection triggers a TNF-dependent osteoporotic phenotype in mice. Life Sci 324:121750","journal-title":"Life Sci"},{"issue":"35","key":"2033_CR59","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.3346\/jkms.2024.39.e237","volume":"39","author":"SH Ra","year":"2024","unstructured":"Ra SH, Chang E, Kwon JS et al (2024) Viral, immunologic, and laboratory parameters in patients with and without post-acute sequelae of SARS-CoV-2 infection (PASC). J Korean Med Sci 39(35):e237 (Erratum in: J Korean Med Sci. 2024;39(38):e304)","journal-title":"J Korean Med Sci"},{"issue":"4","key":"2033_CR60","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/jcp.30047","volume":"236","author":"A Sadeghi","year":"2021","unstructured":"Sadeghi A, Tahmasebi S, Mahmood A et al (2021) Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls. J Cell Physiol 236(4):2829\u20132839","journal-title":"J Cell Physiol"},{"key":"2033_CR61","doi-asserted-by":"publisher","first-page":"1341843","DOI":"10.3389\/fimmu.2024.1341843","volume":"15","author":"S Saito","year":"2024","unstructured":"Saito S, Shahbaz S, Luo X et al (2024) Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome. Front Immunol 15:1341843","journal-title":"Front Immunol"},{"issue":"17","key":"2033_CR62","doi-asserted-by":"publisher","first-page":"9661","DOI":"10.3390\/ijms25179661","volume":"25","author":"K Santana-de Anda","year":"2024","unstructured":"Santana-de Anda K, Torres-Ruiz J, Mej\u00eda-Dom\u00ednguez NR et al (2024) Novel Clinical, Immunological, and Metabolic Features Associated with Persistent Post-Acute COVID-19 Syndrome. Int J Mol Sci 25(17):9661","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2033_CR63","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3390\/v15081704","volume":"15","author":"L Santiago","year":"2023","unstructured":"Santiago L, Gon\u00e7alves-Pereira MH, Vieira MS et al (2023) Compartmentalized regulation of pulmonary and systemic inflammation in critical COVID-19 patients. Viruses 15(8):1704","journal-title":"Viruses"},{"issue":"6","key":"2033_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100663","volume":"3","author":"C Schulthei\u00df","year":"2022","unstructured":"Schulthei\u00df C, Willscher E, Paschold L et al (2022) The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 3(6):100663","journal-title":"Cell Rep Med"},{"key":"2033_CR65","doi-asserted-by":"publisher","first-page":"n136","DOI":"10.1136\/bmj.n136","volume":"372","author":"W Shah","year":"2021","unstructured":"Shah W, Hillman T, Playford ED, Hishmeh L (2021) Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 372:n136 (Erratum in: BMJ. 2022;376:o126)","journal-title":"BMJ"},{"issue":"13","key":"2033_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134253","volume":"12","author":"K Siekacz","year":"2023","unstructured":"Siekacz K, Kumor-Kisielewska A, Mi\u0142kowska-Dymanowska J et al (2023) Oxidative biomarkers associated with the pulmonary manifestation of post-COVID-19 complications. J Clin Med 12(13):4253","journal-title":"J Clin Med"},{"issue":"6578","key":"2033_CR67","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1126\/science.abm2052","volume":"375","author":"S Spudich","year":"2022","unstructured":"Spudich S, Nath A (2022) Nervous system consequences of COVID-19. Science 375(6578):267\u2013269","journal-title":"Science"},{"issue":"9","key":"2033_CR68","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603\u2013605","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"2033_CR69","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1038\/s41598-024-54930-z","volume":"14","author":"N Stepanova","year":"2024","unstructured":"Stepanova N, Driianska V, Rysyev A, Ostapenko T, Kalinina N (2024) IL-6 and IL-17 as potential links between pre-existing hypertension and long-term COVID sequelae in patients undergoing hemodialysis: a multicenter cross-sectional study. Sci Rep 14(1):4968","journal-title":"Sci Rep"},{"issue":"3","key":"2033_CR70","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1093\/cid\/ciac722","volume":"76","author":"Z Swank","year":"2023","unstructured":"Swank Z, Senussi Y, Manickas-Hill Z et al (2023) Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis 76(3):e487\u2013e490","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2033_CR71","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8(5):416\u2013427","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"2033_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-023-01256-1","volume":"24","author":"E Torki","year":"2024","unstructured":"Torki E, Hoseininasab F, Moradi M, Sami R, Sullman MJM, Fouladseresht H (2024) The demographic, laboratory and genetic factors associated with long Covid-19 syndrome: a case-control study. Clin Exp Med 24(1):1","journal-title":"Clin Exp Med"},{"key":"2033_CR73","doi-asserted-by":"crossref","unstructured":"La Torre F, Leonardi L, Giardino G, et al. (2020) Immunological basis of virus-host interaction in COVID-19. Pediatr Allergy Immunol 31 Suppl 26(Suppl 26):75\u201378","DOI":"10.1111\/pai.13363"},{"issue":"4","key":"2033_CR74","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/23744235.2022.2158217","volume":"55","author":"J Torres-Ruiz","year":"2023","unstructured":"Torres-Ruiz J, Lomel\u00edn-Gasc\u00f3n J, Lira Luna J et al (2023) Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot study. Infect Dis 55(4):243\u2013254","journal-title":"Infect Dis"},{"issue":"11","key":"2033_CR75","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","volume":"107","author":"RS Vasan","year":"2003","unstructured":"Vasan RS, Sullivan LM, Roubenoff R et al (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107(11):1486\u20131491","journal-title":"Circulation"},{"issue":"1","key":"2033_CR76","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14(1):135","journal-title":"BMC Med Res Methodol"},{"key":"2033_CR77","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.eclinm.2022.101619","volume":"53","author":"W Wang","year":"2022","unstructured":"Wang W, Wang CY, Wang SI, Wei JC (2022) Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine 53:101619 (Erratum in: <Emphasis Type="Italic">EClinicalMedicine.<\/Emphasis> 2023;59:101968)","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2033_CR78","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/imammb\/dqw021","volume":"35","author":"RS Waters","year":"2018","unstructured":"Waters RS, Perry JSA, Han S, Bielekova B, Gedeon T (2018) The effects of interleukin-2 on immune response regulation. Math Med Biol 35(1):79\u2013119","journal-title":"Math Med Biol"},{"key":"2033_CR79","volume":"2","author":"J Wig\u00e9n","year":"2020","unstructured":"Wig\u00e9n J, L\u00f6fdahl A, Bjermer L, Elowsson-Rendin L, Westergren-Thorsson G (2020) Converging pathways in pulmonary fibrosis and Covid-19 - the fibrotic link to disease severity. Respir Med X 2:100023","journal-title":"Respir Med X"},{"issue":"1","key":"2033_CR80","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1093\/cid\/ciab759","volume":"75","author":"E Wynberg","year":"2022","unstructured":"Wynberg E, van Willigen HDG, Dijkstra M, Boyd A et al (2022) Evolution of coronavirus disease 2019 (COVID-19) symptoms during the first 12 months after illness onset. Clin Infect Dis 75(1):e482\u2013e490","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2033_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.03.034","volume":"11","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhang Y, Xia Y, Sun J (2023) Microbiome and intestinal pathophysiology in post-acute sequelae of COVID-19. Genes Dis 11(3):100978","journal-title":"Genes Dis"},{"issue":"5","key":"2033_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/prca.202200031","volume":"16","author":"J Zhao","year":"2022","unstructured":"Zhao J, Schank M, Wang L et al (2022) Plasma biomarkers for systemic inflammation in COVID-19 survivors. Proteomics Clin Appl 16(5):e2200031","journal-title":"Proteomics Clin Appl"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-02033-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-02033-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-02033-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:03:00Z","timestamp":1769706180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-02033-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2033"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-02033-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involves clinical\u2010epidemiological data of the patients from the published articles, so the informed consent signed by the patients was unnecessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}